Results 191 to 200 of about 93,929 (247)

Selinexor enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by regulating the BAX/Bcl-2/PUMA apoptotic pathway and the XPO1/p27 cell cycle pathway. [PDF]

Front Oncol
Du S, Wang L, Chen C, Sun Y, Liu Q, Shi J, Zhang F, Wang K, Cui C.   +8 more
europepmc   +1 more source

First-line therapies for unresectable hepatocellular carcinoma: a network meta-analysis of immune checkpoint inhibitors and transarterial therapies based on 35 randomized trials. [PDF]

Front Oncol
Zhang H, Zhou S, Dai J, Huang H, Yang B, Huang W, Tang D.   +6 more
europepmc   +1 more source

First-line immunotherapy for advanced hepatocellular carcinoma: a network meta-analysis of randomized trials with overall and HBV/HCV-stratified efficacy and safety. [PDF]

Front Immunol
Chen W, Chen B, Hu C, Wei Q, Zhang L, Fu W.   +5 more
europepmc   +1 more source

Osteopontin-4 (OPN-4) Suppresses Tumor Progression Features Whilst Sensitizing c643 Anaplastic Thyroid Cells to Sorafenib. [PDF]

Biomedicines
Silva GR, Rubim AL, Vasconcelos FDC, Ferreira LB, Greenman J, Gimba ERP.   +5 more
europepmc   +1 more source

Therapeutic Targeting of miR-21 Restores SASH1 and Sensitizes HBV-HCC to Sorafenib. [PDF]

Cancers (Basel)
Han K, Jwa EK, Ha S, Kim J, Lee R, Lee E, Kang S, Kim HO, Kwon H, Jung DH, Yoon YI, Song GW, Park GC, Kim TW, Namgoon JM, Hwang S, Tak E, Lee SG.   +17 more
europepmc   +1 more source

Reversible sorafenib-associated coagulopathy identified by viscoelastic testing in a dog with intranasal sarcoma. [PDF]

J Vet Intern Med
Kim D, Jo Y, Kim S, Choi M, Kim Y.
europepmc   +1 more source

A plain language summary of the CheckMate 9DW study: nivolumab in combination with ipilimumab for unresectable hepatocellular carcinoma (advanced liver cancer). [PDF]

Future Oncol
Yau T, Galle PR, Decaens T, Sangro B, Qin S, da Fonseca LG, Karachiwala H, Blanc JF, Park JW, Gane E, Pinter M, Matilla Peña A, Ikeda M, Tai D, Santoro A, Pizarro G, Chiu CF, Schenker M, He A, Chon HJ, Wojcik-Tomaszewska J, Verset G, Wang QQ, Stromko C, Neely J, Singh P, Jimenez Exposito MJ, Kudo M.   +27 more
europepmc   +1 more source

Systemic Therapies for Desmoid Tumors: A Review of Past, Present, and Future Treatments. [PDF]

Cancers (Basel)
Nahi SL, Dann AM.
europepmc   +1 more source

Elucidating the binding and metabolic interactions of sunitinib and sorafenib with Cytochrome P450s CYP2U1 and CYP2D6. [PDF]

Mol Pharmacol
Tang TY, Li Y, Chapman P, Tajkhorshid E, Das A.   +4 more
europepmc   +1 more source